The pharmacological characteristics of the new anticholinesterase drug aminostigmine
Prozorovskiĭ, V.B.; Pavlova, L.V.; Suslova, I.M.; Shchemeleva, N.I.
Eksperimental'naia i Klinicheskaia Farmakologiia 55(1): 13-16
1992
ISSN/ISBN: 0869-2092 PMID: 1305425 Document Number: 402008
The pharmacological properties of a new drug approved in the USSR for the treatment of cholinolytics poisonings are described. The drug is as active as physostigmine. However, its action is longer. Aminostigmine exhibits marked central effects, which forms the basis for its use for elimination of brain dysfunctions caused by choline blockers.